Systematic Review and Meta-Analysis of the Blood Glutathione Redox State in Chronic Obstructive Pulmonary Disease.

Published on Nov 18, 2020in Antioxidants5.014
· DOI :10.3390/ANTIOX9111146
Salvatore Sotgia25
Estimated H-index: 25
(University of Sassari),
Panagiotis Paliogiannis19
Estimated H-index: 19
(University of Sassari)
+ 7 AuthorsAngelo Zinellu31
Estimated H-index: 31
(University of Sassari)
Sources
Abstract
The aim of this systematic review and meta-analysis was to assess the blood concentrations of the total and reduced forms of the low-molecular-weight antioxidant thiol glutathione (GSH) in chronic obstructive pulmonary disease (COPD) patients in comparison to healthy individuals. A literature search was conducted in the PubMed and Web of Science databases from inception until June 2020. In the 18 studies identified (involving a total of 974 COPD patients and 631 healthy controls), the pooled reduced GSH concentrations were significantly lower in patients with COPD than controls (SMD  =  −3.04, 95% CI = −4.42 to −1.67; p  <  0.001). By contrast, the pooled total GSH concentrations were significantly higher in patients with COPD than controls (SMD = 0.42, 95% CI = 0.11 to 0.73; p = 0.009). Our meta-analysis showed that the blood concentrations of reduced GSH, even in the presence of higher total GSH concentrations, were significantly lower in patients with COPD when compared to healthy controls. This suggests that an impaired antioxidant defense system plays an important role in the pathogenesis of COPD.
References53
Newest
#1Angelo Zinellu (University of Sassari)H-Index: 31
#2Elisabetta ZinelluH-Index: 16
Last. Pietro Pirina (University of Sassari)H-Index: 26
view all 11 authors...
It is amply reported that patients with chronic obstructive pulmonary disease (COPD) have increased risk of cardiovascular disease (CVD). Recent evidence suggests that COPD patients have elevated concentrations of plasma homocysteine (Hcy), a transsulfuration pathway analyte that is commonly regarded as a CVD risk factor. We comprehensively investigated the plasma concentrations of transsulfuration pathway analytes, and their relationship with markers of oxidative stress and inflammation, to ide...
6 CitationsSource
1 CitationsSource
#1Panagiotis Paliogiannis (University of Sassari)H-Index: 19
#2Alessandro G. Fois (University of Sassari)H-Index: 17
Last. Angelo Zinellu (University of Sassari)H-Index: 31
view all 8 authors...
: The aim of this meta-analysis was to review the available evidence regarding the blood concentrations of the oxidative stress marker malondialdehyde (MDA) in chronic obstructive pulmonary disease (COPD) patients in comparison to healthy individuals. 14 studies were included in the meta-analysis (from inception to October 2017) with a total of 817 COPD patients and 530 healthy controls. Pooled MDA concentrations were significantly higher in patients with COPD than controls (standardized mean di...
9 CitationsSource
#1Shumonta Quaderi (UCL: University College London)H-Index: 5
#2John R. Hurst (UCL: University College London)H-Index: 51
123 CitationsSource
#1Yuzo Kodama (Juntendo University)H-Index: 35
#2Yuki KishimotoH-Index: 6
Last. Akihito IshigamiH-Index: 38
view all 16 authors...
Background Few studies to date have investigated the antioxidant nutrients such as vitamin C (ascorbic acid), vitamin E (α-tocopherol), retinol and carotenoids in plasma from patients with pulmonary disease in Japan. To clarify the role of antioxidant nutrients such as vitamin C, vitamin E, retinol and various carotenoids in plasma of Japanese patients with chronic obstructive lung diseases (COPD), asthma-COPD overlap syndrome (ACOS) and/or bronchial asthma (BA), we compared to healthy elderly c...
20 CitationsSource
#2Adel H. Ghoneim (Zagazig University)H-Index: 3
Last. Ibrahim ElmadbouhH-Index: 9
view all 3 authors...
Background: The aim was to evaluate the association of plasma 25-hydroxyvitamin D (25-OHD) and vitamin D binding protein (VDBP or Gc-globin) gene polymorphism with oxidant-antioxidant profiles in patients with chronic obstructive pulmonary disease (COPD), and their role as biomarker risk factors in susceptibility and severity of COPD. Metode: U ovu studiju je ukljuceno 80 pacijenata sa dijagnozom HOBP (blag, umeren i težak oblik na osnovu testova plucne funkcije; FEV 1%) i 80 zdravih kontrolnih ...
16 CitationsSource
#1Angelo Zinellu (University of Sassari)H-Index: 31
#2Alessandro G. Fois (University of Sassari)H-Index: 17
Last. Pietro Pirina (University of Sassari)H-Index: 26
view all 9 authors...
Chronic obstructive pulmonary disease (COPD) and asthma are both characterized by heterogeneous chronic airway inflammation and obstruction as well as oxidative stress (OS). However, it is unknown whether OS occurs in early disease and how to best assess its presence. Plasma OS markers (TBARS, PSH, taurine, GSH, ergothioneine and paraoxonase 1 activity) and lung function tests were measured in patients with mild stable asthma (n = 24) and mild stable COPD (n = 29) and in age- and sex-matched con...
33 CitationsSource
#1Samir El‐Masry (University of Sadat City)H-Index: 3
Last. Mohamed M.N. AboZaid (Zagazig University)H-Index: 2
view all 5 authors...
Abstract Background Chronic obstructive pulmonary disease (COPD) is a common respiratory condition involving the airways and characterized by airflow limitation. Antioxidants are substances that may protect cells from the damage caused by unstable molecules known as free radicals. Antioxidants interact with and stabilize free radicals and may prevent some of the damage free radicals might otherwise cause. Under physiological conditions a balance exists between the amount of reactive oxygen speci...
10 CitationsSource
Chronic obstructive pulmonary disease (COPD), a major cause of death and morbidity worldwide, is characterized by expiratory airflow limitation that is not fully reversible, deregulated chronic inflammation, and emphysematous destruction of the lungs. Despite the fact that COPD is a steadily growing global healthcare problem, the conventional therapies remain palliative, and regenerative approaches for disease management are not available yet. We aim to provide an overview of key reviews, experi...
77 CitationsSource
#1Xiang Wan (Hong Kong Baptist University)H-Index: 16
#2Wenqian Wang (NU: Northwestern University)
Last. Tiejun Tong (Hong Kong Baptist University)H-Index: 17
view all 4 authors...
Background In systematic reviews and meta-analysis, researchers often pool the results of the sample mean and standard deviation from a set of similar clinical trials. A number of the trials, however, reported the study using the median, the minimum and maximum values, and/or the first and third quartiles. Hence, in order to combine results, one may have to estimate the sample mean and standard deviation for such trials.
2,373 CitationsSource
Cited By2
Newest
#1Liyun QinH-Index: 2
#2Maria Guitart (Autonomous University of Barcelona)
Last. Esther BarreiroH-Index: 59
view all 8 authors...
Lung cancer (LC) risk increases in patients with chronic respiratory diseases (COPD). MicroRNAs and redox imbalance are involved in lung tumorigenesis in COPD patients. Whether systemic alterations of those events may also take place in LC patients remains unknown. Our objectives were to assess the plasma levels of microRNAs, redox balance, and cytokines in LC patients with/without COPD. MicroRNAs (RT-PCR) involved in LC, oxidized DNA, MDA-protein adducts, GSH, TEAC, VEGF, and TGF-beta (ELISA) w...
Source
#1Salvatore SotgiaH-Index: 25
#2Alessandro G. FoisH-Index: 17
Last. Angelo ZinelluH-Index: 31
view all 6 authors...
This study aimed to review and critically appraise the current methodological issues undermining the suitability of the measurement of serum/plasma glutathione, both in the total and reduced form, as a measure of systemic oxidative stress in chronic obstructive pulmonary disease (COPD). Fourteen relevant articles published between 2001 and 2020, in 2003 subjects, 1111 COPD patients, and 892 controls, were reviewed. Nine studies, in 902 COPD patients and 660 controls, measured glutathione (GSH) i...
Source